NRXS Stock Analysis: Buy, Sell, or Hold?

NRXS - Neuraxis, Inc.

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
$7.00
-0.16 (-2.23%) ▼
5d: +2.94%
30d: -5.79%
90d: -4.24%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026

Get Alerted When NRXS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: NRXS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: NRXS is currently trading at $7.00, which is considered fair relative to its 30-day fair value range of $6.80 to $7.40.

Technical Outlook: Technically, NRXS is in a strong uptrend. Immediate support is located at $6.38, while resistance sits at $7.69.

Market Sentiment: NRXS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+57.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $6.80 - $7.40
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 57.1% below Wall St target ($11.00)

Trading Range Analysis

30-Day Trading Range $6.80 - $7.40
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $6.38
Resistance Level $7.69
Current Trend Strong Uptrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -116.67
Wall Street Target $11.00 (+57.1%)
Revenue Growth (YoY) 79.5%
Profit Margin -170.1%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 23, 2026 8:21 PM ET
Data refreshes hourly during market hours. Next update: 9:21 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Brian Allen Carrico BUY 8060 shares 2026-04-01
Thomas Joeseph Carrico BUY 667 shares 2026-04-01
Timothy Robert Henrichs BUY 7593 shares 2026-04-01

Unlock Insider Activity

See real-time buying/selling by company executives for NRXS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$27 56 HOLD
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$412 57 HOLD
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1022 67 BUY
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD

More Analysis for NRXS

NRXS Technical Chart NRXS Price Prediction NRXS Earnings Date NRXS Investment Advisor NRXS Fair Price Analyzer NRXS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals